VYTRUS BIOTECH EO -,01 financial statements, including revenue, expenses, and profit

The total revenue of V5P for the last semiannual is 2.50 M EUR, and it's 28.21% higher compared to the previous semiannual. The net income of H1 24 is 510.72 k EUR.